Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index; 3 of the 34 sources its claims cite were checked for support.

Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update

Open access

Abstract

This report describes updates to the National Safety Council's Alcohol, Drugs and Impairment Division's recommendations for drug testing in driving under the influence of drug (DUID) cases and motor vehicle fatalities. The updates are based on a survey of drug testing practices in laboratories in the USA and Canada, a comprehensive review of the prior recommendations and data and research on drugs most frequently detected in DUID cases. A consensus meeting was held with representative forensic science practitioners and the authors of this report to update recommendations. No changes were made to the Tier I scope; however, there were changes to cutoffs of some analytes for blood, urine and oral fluid. Due to increased prevalence in DUID cases, trazodone and difluoroethane were added to the Tier II scope. For clarification, Tier I cutoffs reflect free concentrations, and hydrolysis is recommended but not required. The consensus panel concluded that urine is an inferior matrix to blood and oral fluid as it may represent historical use or exposure unrelated to observed impairment; therefore, future iterations of these recommendations will not include urine as a recommended matrix. Laboratories currently testing urine should work with traffic safety partners to encourage the use of blood and oral fluid as more appropriate specimens and adjust their capabilities to provide that testing.

Overview

CoChat Summary

TL;DR

This 2021 update revises the National Safety Council’s Alcohol, Drugs and Impairment Division recommendations for toxicological testing in drug-impaired driving and motor vehicle fatality cases. It retains the Tier I scope, makes selected cutoff changes, adds trazodone and difluoroethane to Tier II, and states that future iterations will no longer include urine as a recommended matrix.

Key findings

  • No changes were made to Tier I compound scope; cutoff changes included raising carisoprodol screening/confirmation to 1,000 ng/mL, removing meprobamate urine and oral fluid screening cutoffs, raising norbuprenorphine blood confirmation to 1 ng/mL, and raising fentanyl urine confirmation to 1 ng/mL.
  • Trazodone and difluoroethane were added to Tier II due to increased prevalence; Tier II also includes classes such as synthetic cannabinoids, cathinones, novel benzodiazepines, fentanyl analogs, and novel opioids.
  • In the 2020 survey of 65 laboratories, 89% tested blood, 63% tested urine, and 3% tested oral fluid; 45% reported a stop-testing policy, with 34% of those stopping at 0.08 g/dL and 41% at 0.10 g/dL.
  • Compliance with 2017 blood scope/cutoffs was 12% meeting or exceeding all recommendations, 40% partial compliance with active method development, 19% disagreeing with some aspect, and 44% close to meeting recommendations.
  • The consensus panel concluded urine is inferior to blood and oral fluid because it may represent historical use or exposure unrelated to observed impairment; future iterations will not include urine as a recommended matrix.

Methods

  • A 2020 SurveyMonkey survey was sent to 325 US and Canadian forensic toxicology laboratory directors; 84 responded, and 65 laboratories completed the survey. Questions covered agency type, staffing, resources, caseload, screening/confirmation technologies, matrices, scope, cutoffs, drug prevalence, and compliance, plus new items on reporting limits, ethanol-based stop-testing, hydrolysis, and urine quantification.
  • A virtual consensus meeting was held in July and August 2020 with a subset of survey respondents (n = 10) and authors, representing AL, AZ, CA, CO, FL, IN, MD, MI, NC, NH, NY, OR, PA, TX, and WI. The panel used a modified Delphi method to review the 2020 survey and 2017 recommendations and re-evaluate scope, cutoffs, and Tier I/Tier II designation.
  • Survey data were analyzed using SurveyMonkey and Microsoft Excel.

Limitations

  • Stated in the paper: laboratories continue to face lack of budget, time, staffing, and instrumentation, which hinders full implementation of the recommendations.
  • Stated in the paper: urine is limited as a matrix because drug presence demonstrates only historical drug use or exposure and does not equate to impairment at the time of collection or proximate to driving.
  • Evident from the text, not framed by the authors as limitations: the survey had 65 completed responses from 325 invited laboratory directors, relied on self-reported practices, and the consensus panel was a subset of 10 respondents plus authors, which may limit generalizability across all laboratories and jurisdictions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/jat/bkab064

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

3 Valid · 3 Not valid · 14 Not checked · 42 Own results and interpretations

19 more claims

Create a free account to see all 62 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 23
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 14 references

Research works printed but not linked: 2

  1. Substance Abuse and Mental Health Services Administration (SAMHSA), 2019, Mandatory Guidelines for Federal Workplace Drug Testing Programs—Oral/Fluid
  2. Construction Owners Association of Alberta, 2018, Alcohol and Drug Guidelines and Work Rule

Cited by

See all 60

Metadata

Authors
D’Orazio, A. L., Mohr, A. L. A., Chan-Hosokawa, A., Harper, C., Huestis, M. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Logan, B. K.
Affiliations
  • Fredric Rieders Family Foundation (US)
  • NMS Labs, 200 Welsh Road, Horsham, PA 19044, USA
  • Alabama Department of Forensic Sciences (US)
  • Huestis and Smith Toxicology, LLC, 683 Shore Road, Severna Park, MD 21146, USA
  • New York City Police Department (US)
  • Wisconsin State Laboratory of Hygiene, 2601 Agriculture Drive, PO Box 7996, Madison, WI 53707-7996, USA
  • New England Forensic Toxicology, LLC, PO Box 702, Concord, NH 03302, USA
  • Sam Houston State University (US)
  • Arcadia University (US)
Corresponding author
Logan, Barry K
Venue
Journal of Analytical Toxicology
Published
2021-06-04
Volume
45
Issue
6
Pages
529-536
ISSN
  • 0146-4760 (ISSN-L)
  • 1945-2403
OpenAlex
W3164982881
Cited by
60
References
14
Citations by year
2026: 5 · 2025: 15 · 2024: 12 · 2023: 12 · 2022: 12 · 2021: 4
FWCI
6.51
Type
journal article
Language
en
Open access
Locations
  • Journal of Analytical Toxicology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Fredric Rieders Family Foundation
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
drug-impaired driving, traffic fatalities, toxicological investigation, blood samples, oral fluid specimens, urine samples, trazodone, forensic toxicology, drug testing laboratories, specimen selection
MeSH terms
Accidents, Traffic, Driving Under the Influence, Automobile Driving, Canada, Pharmaceutical Preparations, Humans, Substance Abuse Detection, Motor Vehicles, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update. https://app.cochat.ai/papers/10.1093/jat/bkab064
The paper
D’Orazio, A. L., Mohr, A. L. A., Chan-Hosokawa, A., Harper, C., Huestis, M. A., Limoges, J. F., Miles, A. K., Scarneo, C. E., Kerrigan, S., Liddicoat, L. J., Scott, K. S., & Logan, B. K. (2021). Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkab064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.